V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria (Q34171212)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q89108863)
(P304) 840-847
(P407) (Q1860)
(P433) 2
(P478) 92
(P577) Sunday, August 1, 1993
(P921) (Q1415366)
(Q79460)
(Q134808)
(Q422248)
(P1433) (Q3186904)
(P1476) "V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria" (language: en)
(P2093) D C Montefiori
J Zhou
J Zhou
R A Bucco
D H Schwartz
L A Cavacini
M R Posner
(P2860) (Q29547463)
(Q34253011)
(Q28259668)
(Q28646817)
(Q40191379)
(Q45837045)
(Q55244821)
(Q36881981)
(Q34301897)
(Q44021595)
(Q42939897)
(Q33571605)
(Q33560772)
(Q37412527)
(Q38891686)
(Q37675018)
(Q36795606)
(Q34214455)
(Q37548597)
(Q37375345)
(Q45854355)
(Q40059024)
(Q45856562)
(Q47571809)
(Q36862176)
(Q46352552)
(Q36656386)
(Q44119196)
(Q42129803)
(Q36821885)
(Q41679452)
(Q44809362)
(Q40062738)
(Q44298917)
(Q43414762)
(Q44761396)
(Q41645847)
(Q40308489)
(Q33937274)
(Q41632477)
(Q44046385)
(Q41597581)
(Q41582091)
(Q45780030)
(Q45018234)
(Q45853395)
(Q68145401)
other details
description scientific article

External Links